Cytel invites you to an interactive Office Hours session with Angela Vinken, Jürgen Hummel, and Flaminia Chiesa, moderated by Nelia Padilla.

Even the strongest trial designs can face challenges once execution begins. Assumptions made early on do not always hold in practice, and disconnects between involved partners on the design and delivery can affect timelines, data quality, and ultimately the value of your study.

In this informal Office Hours session, you can bring your questions directly to our experts across trial design and execution. Whether you are planning a complex study, navigating Phase II decisions, or thinking ahead on regulatory and commercial needs, this is a chance to discuss real-world challenges and get practical input.

What can you ask?

• How can we ensure our trial design is feasible from an operational perspective?
• What are common misconceptions and pitfalls when moving from design to execution?
• How should we think about endpoints and data strategy early on?
• What should we consider in Phase II to support future regulatory and commercial success?
• How do complex or adaptive designs impact study delivery?

Speakers

• Angela Vinken, Global Head, Portfolio Leadership
• Jürgen Hummel, Vice President, Innovative Statistics
• Flaminia Chiesa, Senior Director, Regional Head of Biostatistics
• Nelia Padilla, Vice President, Consulting Strategy & Operations